Mesirow Financial Investment Management Equity & Fixed Income Biomarin Pharmaceutical Inc Transaction History

Mesirow Financial Investment Management Equity & Fixed Income

$97.3 Million
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 08, 2022	BUY	$71.48 - $86.85 $1.42 Million - $1.73 Million	19,875 New	19,875 $1.65 Million

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.44 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.22 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.2 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$881 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$666 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.

Account